Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review

RATIONALE: Locoregional recurrence of breast cancer is a challenging issue for clinicians. Treatment options for unresectable recurrent estrogen receptor positive (ER+) breast cancer in previously irradiated area are limited. Some studies showed concomitant fulvestrant with radiation therapy might i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jingxian, Guo, Yonghong, Jiang, Xiaoliu, Li, Kai, Fu, Wenbing, Cao, Yali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387012/
https://www.ncbi.nlm.nih.gov/pubmed/32791733
http://dx.doi.org/10.1097/MD.0000000000021344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387012/
https://www.ncbi.nlm.nih.gov/pubmed/32791733
http://dx.doi.org/10.1097/MD.0000000000021344

Ejemplares similares